Zusammenfassung
Intrazerebrale Blutungen (ICB) und kardiale Erkrankungen sind auf vielfache Weise verknüpft: Liegen systemische Erkrankungen des kollagenen Bindegewebes vor, so können Patienten, die unter kardial indizierter Antikoagulation stehen, von einer ICB betroffen sein. Das korrekte Management ist dann oft schwierig und von schmalem Grat. Das Kapitel thematisiert diese Fallstricke und versucht, auf Basis der aktuellen Studienlage möglichst praxisnahe Empfehlungen für den klinischen Alltag auszusprechen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Cannon CP, Bhatt DL, Oldgren J et al. (2017) Dual antithrombotic therapy with Dabigatran after PCI in atrial fibrillation. N Engl J Med 377: 1513–1524
Chen YW, Li CH, Yang CD et al. (2017) Low cholesterol level associated with severity and outcome of spontaneous intracerebral hemorrhage: Results from Taiwan Stroke Registry. PLoS One 12: e0171379
Deutsches Ärzteblatt (2015) Perspektiven der Kardiologie. Dtsches Ärztebl 1/2015
Dewilde WJ, Oirbans T, Verheugt FW et al. (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial. Lancet 381: 1107–1115
DGK – Deutsche Gesellschaft für Kardiologie (2014) Management der akuten Lungenembolie. http://leitlinien.dgk.org/files/2015_PLL_Lungenembolie_internet1.pdf. Zugegriffen: 25.10.2017
Es van N, Coppens M, Schulman S et al. (2014) Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood 124: 1968–1975
Gibson CM, Mehran R, Bode C et al. (2016) Prevention of bleeding in patients with atrial fibrillation undergoing PCI. New Engl J Med 375: 2423–2434
Hacke W (Hrsg) (2015) Neurologie, 14. Aufl. Springer, Heidelberg
Hanggi, D, Steiger HJ (2008) Spontaneous intracerebral haemorrhage in adults: A literature overview. Acta Neurochirurgica 150: 371–379
Hemphill JC 3rd Greenberg SM, Anderson CS et al. (2015) Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 46: 2032–2060
Hess CN, Petersen ED, Peng SA et al. (2015) Use and outcomes of triple therapy among older patients with acute myocardial infarction and atrial fibrillation. JACC 66: 616–627
Huang KT, Bi WL, Abd-El-Barr M et al. (2016) The neurocritical and neurosurgical care of subdural hematomas. Neurocritical Care 34: 294–307
Kretschmer T, Schmidt T (2017) Intrakranielle Blutungen. In: Litmathe (Hrsg) Neurologische Notfälle. Springer, Heidelberg, S 25–63
Krittalak K, Sawanyawisuth K, Tiamkao S (2011) Safety of withholding anticoagulation in patients with mechanical prosthetic valves and intracranial haemorrhage. Intern Med J 41: 750–754
Kuramatsu JB, Gerner ST, Schellinger PD et al. (2015) Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA 313: 824–836
Lamberts M, Gislason GH, Lip GY et al. (2014) Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: A nationwide cohort study. Circulation 129: 1577–1584
Lopez RD, Guimaraes PO, Kolls BJ et al. (2017) Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy. Blood 129: 2980–2987
Kuramatsu JB, Sembill JA, Gerner ST et al. (2018) Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves. Eur Heart J 2018 39(19): 1709–1723
Panduranga P, Al-Mukhaini M, Al-Muslahi M et al. (2012) Management dilemmas in patients with mechanical heart valves and warfarin-induced major bleeding. World J Cardiol 26: 54–59
Pennlert J, Overholser R, Asplund K et al. (2017) Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation. Stroke 48: 414–320
Pollack CV Jr, Reilly PA, van Ryn J et al. (2017) Idarucizumab for Dabigatran reversal – Full cohort analysis. New Engl J Med 377: 431–441
Qureshi AI, Giles WH, Croft J B (1999) Racial differences in the incidence of intracerebral hemorrhage: Effects of blood pressure and education. Neurology 52: 1617–1621
Qureshi AI, Tuhrim S, Broderick JP, Batjer HH et al. (2001) Spontaneous intracerebral hemorrhage. New Engl J Med 344: 1450–1460
Raj R, Mikkonen ED, Kivisaari R et al. (2016) Mortality in elderly patients operated for an acute subdural hematoma: A surgical case series. World Neurosurg 88: 592–597
Schievink WI, Raissi SS, Maya MM et al. (2010) Screening for intracranial aneurysms in patients with bicuspid aortic valve. Neurology 74: 1430–1433
Vlak MH, Algra A, Brandenburg R et al. (2011) Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: A systematic review and meta-analysis. Lancet Neurol 10: 626–636
Wilson D, Seiffge DJ, Traenka C et al. (2017) Outcome of intracerebral hemorrhage associated with different oral anticoagulants. Neurology 88: 1693–1700
Windecker S, Kolh P, Collet JP et al. (2014) 2014 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 35: 2541–2619
Yao X, Abraham NS, Sangaralingham LR et al. (2016) Effectiveness and safety of Dabigatran, Rivaroxaban, and Apixaban versus Warfarin in nonvalvular atrial fibrillation. J Am Heart Assoc 5: e003725
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Litmathe, J. (2019). Kardiologische Aspekte bei intrakraniellen Blutungen (ICB). In: Neuro-Kardiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57644-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-662-57644-1_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-57643-4
Online ISBN: 978-3-662-57644-1
eBook Packages: Medicine (German Language)